GPT-5 Runs an Autonomous Biotech Lab, Designs 36,000 Experiments for Ginkgo Bioworks
OpenAI connected GPT-5 to Ginkgo Bioworks' robotic lab and let it design, execute, and iterate on protein synthesis experiments — achieving a 40% cost reduction and a new state of the art in cell-free protein synthesis.
Ginkgo Bioworks announced Thursday that it connected its autonomous laboratory infrastructure to OpenAI's GPT-5, allowing the model to design experiments, analyze results, and iterate — all without human intervention in the loop. According to @Ginkgo, the system achieved a new state of the art for cell-free protein synthesis while reducing costs by 40%.
Unlock the full briefing
Get every story in today's briefing, the full archive, and the daily AI intelligence brief.
All stories today
Full archive
Daily brief
Cancel anytime. Payments powered by Stripe.